N@N

Study finds GLP-1s had multiple health benefits

The article from MSN discusses a study on GLP-1 agonists, a class of drugs typically used for managing type 2 diabetes, which have shown multiple health benefits beyond just blood sugar control. According to the research, these medications, which include popular drugs like Ozempic and Wegovy, not only aid in weight loss but also reduce the risk of cardiovascular events like heart attacks and strokes. The study highlighted that GLP-1 agonists can decrease the likelihood of developing kidney disease, lower blood pressure, and even reduce the risk of certain cancers. These findings suggest that GLP-1 agonists could play a broader role in preventive healthcare, potentially extending their use to patients without diabetes but at risk for cardiovascular diseases or obesity-related conditions. However, the article also notes that while these drugs offer significant benefits, they come with side effects like nausea and potential long-term risks that need further investigation.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/diseases-and-conditions/study-finds-glp-1s-had-multiple-health-benefits/ar-AA1xzVO6 ]